drugset / Trial / NCT00909324

Efficacy, Tolerability, and Comfort of 0.3% Hypromellose Eyedrops in Patients Undergoing LASIK Surgery

NCT00909324

Phase 4 Completed 170 enrolled Novartis Pharmaceuticals
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is designed to assess the tolerability and comfort of peri-operative 0.3% hypromellose eye drops in LASIK surgery patients and to assess whether pre-operative 0.3% hypromellose eye drops add to post-operative comfort in LASIK surgery patients compared to control (no pre-operative lubricant).

Timeline

Start
2009-08-01
Primary completion
2010-01-01
Completion
2010-01-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Hypromellose Unknown 0.3 % Other

Indications